Fundraising Fox

Blade Therapeutics

South San Francisco, US · Founded 2015 · Delaware corporation · 7 known investors

Biotech

Founders & leadership

WR
Wendye RobbinsExecutive

Board

LELuke Evnin
Luke Evninin𝕏Board directorAdvisor at MPM BioImpact
CW
Cameron WheelerBoard director
PVPeter van Vlasselaer
Peter van VlasselaerBoard directorVenture Partner at +ND Capital
EJ
Elaine JonesBoard director
WS
William SlatteryBoard director
JS
James ScopaBoard director

Investors · 7

Bay City CapitalSan Rafael · $5M – $10M
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
Pfizer Venture Investments$5M – $20M
+ND CapitalreportedWoodside · $540K – $5.4Mvia Peter Van Vlasselaer · board
Deerfield Management CompanyreportedNew York
MPM BioImpactreported · 2 sourcesBoston · $1M – $15Mvia Luke Evnin · board
Osage University PartnersreportedBala Cynwyd

Reported raises · per SEC filings

Form D private placements

$77M disclosed across 3 rounds · 2016–2019

▶$12MraisedOct 2019 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Prabha IbrahimExecutive Officer
  • William V. SlatteryDirector
  • James ScopaDirector
  • Gary PatouExecutive Officer
  • Lloyd B. KlicksteinDirector
  • Cameron WheelerDirector
  • Peter Van VlasselaerDirector
  • Luke EvninDirector
  • Wendye Rae RobbinsExecutive Officer, Director
  • Rana Al-HallaqDirector
  • M. Shirley ChiangExecutive Officer
Offering amount
$24M
Amount sold
$12M
First sale
Sep 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38MraisedOct 2019 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rana Al-HallaqDirector
  • Wendye Rae RobbinsExecutive Officer, Director
  • William V. SlatteryDirector
  • James ScopaDirector
  • Gary PatouExecutive Officer
  • Lloyd B. KlicksteinDirector
  • Prabha IbrahimExecutive Officer
  • M. Shirley ChiangExecutive Officer
  • Cameron WheelerDirector
  • Peter Van VlasselaerDirector
  • Luke EvninDirector
Offering amount
$50M
Amount sold
$38M
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$27.1MraisedJun 2016 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Luke EvninDirector
  • Cameron WheelerDirector
  • Peter van VlasselaerDirector
  • Elaine JonesDirector
  • Wendye RobbinsExecutive Officer, Director
  • William SlatteryDirector
  • James ScopaDirector
Offering amount
$45.4M
Amount sold
$27.1M
First sale
Jun 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Blade Therapeutics went on to found or lead other companies.

Luke EvninDirectorFounded Mpmcapital +1Wendye RobbinsPresident and Chief Executive Officer (formerly Interim CEO)Founded Limerick Biopharma

In the news

Blade Therapeutics Closes Second Tranche of Series B Financing - FinSMEsfinsmes.com · Oct 2017Blade helps itself to $45m slice - Global Venturingglobalventuring.com · Jun 2016Bay Area Startup Blade Therapeutics Rakes in $45 Million - BioSpacebiospace.com · Jun 2016Blade Therapeutics : Raises $45 Million Series B Financing with Unparalleled Syndicate of VCs and Strategic Pharma Investors | MarketScreenermarketscreener.com · Jun 2016Biopharmaceutical Company Blade Therapeutics Raises up to $45M in Series B Financing - FinSMEsfinsmes.com · Jun 2016

Frequently asked questions

Who are Blade Therapeutics's investors?
Blade Therapeutics's investors include Bay City Capital, OUP (Osage University Partners), Pfizer Venture Investments, +ND Capital, Deerfield Management Company, MPM BioImpact, Osage University Partners.
How much funding has Blade Therapeutics raised?
Blade Therapeutics has disclosed $77M raised across 3 rounds.
Where is Blade Therapeutics headquartered?
Blade Therapeutics is headquartered in South San Francisco, US.